Distinct P53 Gene Signatures Are Needed to Predict Prognosis and Response to Chemotherapy in ER-Positive and ER-Negative Breast Cancers

Clinical Cancer Research - United States
doi 10.1158/1078-0432.ccr-10-1045
Full Text
Abstract

Available in full text

Date
Authors
Publisher

American Association for Cancer Research (AACR)

Related search

Distinct Genes Related to Drug Response Identified in ER Positive and ER Negative Breast Cancer Cell Lines

PLoS ONE
Multidisciplinary
2012English

Estrogen Receptor (ER) mRNA Expression and Molecular Subtype Distribution in ER-negative/progesterone Receptor-Positive Breast Cancers

Breast Cancer Research and Treatment
Cancer ResearchOncology
2013English

Novel Immunohistochemistry-Based Signatures to Predict Metastatic Site of Triple-Negative Breast Cancers

British Journal of Cancer
Cancer ResearchOncology
2017English

The Combination of Tamoxifen and the Rexinoid LG100268 Prevents ER-Positive and ER-Negative Mammary Tumors in P53-Null Mammary Gland Mice

Cancer Prevention Research
MedicineCancer ResearchOncology
2012English

A Robust Classifier of High Predictive Value to Identify Good Prognosis Patients in ER-negative Breast Cancer

Breast Cancer Research
Cancer ResearchOncology
2008English

Estrogen Receptor (ER ) Level but Not Its ER Cx Variant Helps to Predict Tamoxifen Resistance in Breast Cancer

Clinical Cancer Research
Cancer ResearchOncology
2004English

A Gene Signature of Loss of Oestrogen Receptor (ER) Function and Oxidative Stress Links ER-positive Breast Tumours With an Absent Progesterone Receptor and a Poor Prognosis

Breast Cancer Research
Cancer ResearchOncology
2008English

Gene Expression-Based Predictive Markers for Paclitaxel Treatment in ER+ and ER− Breast Cancer

Frontiers in Genetics
GeneticsMolecular Medicine
2019English

The Integrin v 3-5 Ligand MFG-E8 Is a P63/P73 Target Gene in Triple-Negative Breast Cancers but Exhibits Suppressive Functions in ER+ and erbB2+ Breast Cancers

Cancer Research
Cancer ResearchOncology
2010English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy